Clinical Trial Update: Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim [Phase 2]

View source ↗

Summary

A Phase 2 interventional trial in adults with immune thrombocytopenia purpura (idiopathic thrombocytopenic purpura) on romiplostim has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia Purpura

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: Amgen | Conditions: Idiopathic Thrombocytopenic Purpura | Phase 2 | Status: COMPLETED | Results posted: 2016-02-24